Chapter 8 — Case Study 2: The Sharpless Epoxidation — Predictive Asymmetric Synthesis

"The Sharpless epoxidation is the textbook example of asymmetric synthesis. It uses cheap reagents, gives high ee, has predictable stereochemistry from the catalyst's chirality, and works on a wide range of substrates. It is the kind of reaction that has changed the practice of pharmaceutical synthesis." — paraphrase from a synthesis textbook

This case study explores the Sharpless asymmetric epoxidation in detail — its mechanism, predictive power, scope, and impact on natural product and drug synthesis. The reaction won K. Barry Sharpless the 2001 Nobel Prize in Chemistry (shared with Knowles and Noyori).

What is the Sharpless epoxidation?

The Sharpless asymmetric epoxidation converts:

$$\text{allylic alcohol} + \text{tBu-OOH (peroxide)} + \text{chiral Ti(OiPr)}_4/\text{tartrate catalyst} \to \text{chiral epoxide}$$

Specifically: - Substrate: an allylic alcohol (R-CH=CH-CH₂OH) — the OH is essential. - Oxidant: tert-butyl hydroperoxide (TBHP). - Catalyst: titanium isopropoxide [Ti(OiPr)₄] + chiral diisopropyl tartrate (DIPT). - Product: a 2,3-epoxy alcohol with high enantiomeric excess (typically 90-95% ee).

The catalyst is regenerated each cycle, so the chiral tartrate is used in catalytic (~10 mol%) amounts.

A specific example

Cinnamyl alcohol (Ph-CH=CH-CH₂OH) + (R,R)-DIPT/Ti + TBHP → (2S,3S)-2,3-epoxy-3-phenyl-1-propanol in ~95% ee.

The epoxide oxygen is delivered to one specific face of the alkene, controlled by the chirality of the tartrate catalyst.

The Sharpless mnemonic

Sharpless devised a memorable mnemonic for predicting the product:

Draw the allylic alcohol with: - The C=C horizontal. - The CH₂-OH on the right (with -OH on the right). - The substituent on the left.

Then: - (+)-DIPT (from L-tartaric acid) catalyzes oxygen delivery from below the plane (bottom face). - (−)-DIPT (from D-tartaric acid) catalyzes oxygen delivery from above the plane (top face).

This gives a predictable absolute configuration of the epoxide. Both enantiomers of the catalyst are commercially available, so a chemist can choose which enantiomer of the epoxide to make.

This predictive power is unprecedented in asymmetric synthesis. Most asymmetric methods give one enantiomer; you have to find a different catalyst or chiral pool starting material to get the other. With Sharpless, both enantiomers are accessible just by choosing the catalyst.

Mechanism overview

The active catalyst is a chiral titanium tartrate complex with two TBHP molecules and the allylic alcohol's -OH coordinated:

$$\text{Ti(O}t\text{Bu)}_x(\text{tartrate})\text{ + ROH (substrate) + tBu-OOH}$$

The complex orients the alkene so that one face is positioned for oxygen transfer. The oxygen of tBu-OOH is delivered to the alkene; tert-butanol leaves; the epoxide is formed.

The chirality of the tartrate determines which face of the alkene is attacked. The substrate's -OH is essential because it coordinates to the titanium and orients the alkene.

The detailed mechanism involves a dimeric titanium complex with two tartrate ligands, but the simplified picture above captures the essential stereochemical control.

Why is this so useful?

High ee

The Sharpless epoxidation routinely gives 90-95% ee on a wide range of allylic alcohols. For some substrates, ee approaches 99%.

Wide scope

Works on: - Mono-, di-, tri-, and tetra-substituted alkenes (with the allylic -OH). - (E)- and (Z)-alkenes (different products!). - Both small and large substrates.

Predictable stereochemistry

The mnemonic predicts the absolute configuration of the product without needing experimental verification.

Catalytic

Only 5-10 mol% catalyst is needed. The chiral tartrate is recovered easily.

Well-developed sample preparation

Both (R,R)- and (S,S)-DIPT are commercially available. The active Ti-tartrate catalyst is generated in situ from Ti(OiPr)₄ + DIPT in methylene chloride.

Accessible

Reagent costs are modest; reactions are conducted in standard glassware; the products are often crystalline.

Applications in synthesis

The Sharpless epoxidation has been used for the synthesis of countless natural products and drugs:

Erythromycin (antibiotic)

Sharpless epoxidation of an allylic alcohol intermediate in Woodward's classic synthesis of erythromycin (a 14-membered macrolide antibiotic).

Ginkgolide B

This complex natural product (anti-anti-inflammatory) was synthesized by Corey using a Sharpless epoxidation as a key step.

Triptolide

A natural product with anti-cancer activity; synthesized using Sharpless epoxidation as the key step in installing a critical stereocenter.

Many statins

Cholesterol-lowering drugs (Lipitor, Crestor) have been made using Sharpless epoxidation as a key step in pharmaceutical processes.

β-blockers

Many β-adrenergic blockers (atenolol, metoprolol) have been synthesized using Sharpless epoxidation to install the critical 2,3-epoxide intermediate.

Antifungal drugs

Itraconazole, ketoconazole synthesis steps use Sharpless-related chemistry.

Beyond the basic Sharpless epoxidation

The Sharpless name now extends to several related asymmetric reactions:

Sharpless asymmetric dihydroxylation (1988)

Uses OsO₄ + chiral cinchona alkaloid ligand. Gives a chiral 1,2-diol from a prochiral alkene.

Reagent kits: AD-mix-α and AD-mix-β (premixed; just add to alkene + water + tBuOH). Easy to use.

Sharpless asymmetric aminohydroxylation

Uses OsO₄ + chiral cinchona ligand + an amine source. Gives a chiral β-amino alcohol from a prochiral alkene.

Click chemistry (Sharpless's second Nobel)

The CuAAC (Cu-catalyzed azide-alkyne cycloaddition) is "click chemistry" — Sharpless coined the term. Won him the 2022 Nobel Prize. Different chemistry from epoxidation, but reflects the same philosophy: simple, reliable reactions with high yield and selectivity.

Limitations

The Sharpless epoxidation requires: - An allylic alcohol substrate (the -OH is essential). Without it, the reaction doesn't work. - A relatively unreactive substrate (highly conjugated alkenes may give over-oxidation). - Tolerance to anhydrous conditions (water competes with the catalyst).

Substrates without -OH need different methods (Jacobsen-Katsuki epoxidation with Mn-salen catalysts; or Shi epoxidation with chiral fructose-derived ketone).

What Chapter 8 has taught

You now understand: - Why the chirality of the catalyst matters: the Ti-DIPT catalyst is itself chiral and presents one face of the alkene to the oxidant preferentially. - Why the product configuration is predictable: the chirality of the catalyst determines which face is attacked. - What "asymmetric induction" means: a chiral environment biases an otherwise prochiral reaction. - What "stereoselective" vs "stereospecific" means: Sharpless is stereoselective (high ee, kinetic preference); not stereospecific (it's an enantio-discriminating reaction, not a substrate-stereochemistry-discriminating one).

The Sharpless epoxidation is the textbook example of how Chapter 8's principles (mechanism + chirality of catalyst → predictable stereochemistry) translate into practical, industrially important asymmetric synthesis.

Take-home

• The Sharpless asymmetric epoxidation converts allylic alcohols to chiral epoxides using a chiral Ti-tartrate catalyst.
• Predictable stereochemistry: the Sharpless mnemonic predicts the absolute configuration of the product from the catalyst's chirality.
• Wide scope (mono-, di-, tri-, tetrasubstituted allylic alcohols).
• High ee (typically 90-95%).
• Catalytic in chirality (5-10 mol% tartrate).
• 2001 Nobel Prize in Chemistry (shared with Knowles and Noyori).
• Used industrially for the synthesis of antibiotics, β-blockers, statins, antifungal drugs, natural products.
• Related reactions: Sharpless asymmetric dihydroxylation (with OsO₄/cinchona); Sharpless asymmetric aminohydroxylation; click chemistry (Sharpless's 2022 second Nobel).
• Mastery of Chapter 8 lets you understand why this reaction works and predict its outcomes.

Further reading

• Sharpless, K. B. (2002). "Searching for new reactivity (Nobel Lecture)." Angew. Chem. Int. Ed. 41, 2024-2032.
• Katsuki, T.; Sharpless, K. B. (1980). "The first practical method for asymmetric epoxidation." J. Am. Chem. Soc. 102, 5974-5976.
• Finn, M. G.; Sharpless, K. B. (1991). "On the mechanism of asymmetric epoxidation with titanium-tartrate catalysts." J. Am. Chem. Soc. 113, 113-126.
• Pfaltz, A.; Drury, W. J. III. (2004). "Design of chiral ligands for asymmetric catalysis: From C₂-symmetric P,P- and N,N-ligands to sterically and electronically nonsymmetrical P,N-ligands." Proc. Natl. Acad. Sci. USA 101, 5723-5726.